Monday, December 23, 2024
HomeTagsBiologics

Biologics

NTx Secures $15M Venture Debt from J.P. Morgan for Biomanufacturing Expansion

Nature’s Toolbox, Inc. (NTx), a life science company developing domestically-sourced biomanufacturing solutions for the delivery of personalized therapeutics and biologics, announced it secured $15...

Abzena and Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies

Abzena, the leading end-to-end integrated contract and development manufacturing organization for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a cGMP CDMO serving...

Abzena Launches EpiScreen® 2.0, a Next Generation Immunogenicity Tool for De-Risking the Development of Complex Biologics and Bioconjugates

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of...

Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced that it has reached an agreement with Biogen for the buyout of Biogen's stake in the Samsung Bioepis joint...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics